A clinical trial to Evaluate safety and efficacy of bolus dose versus fractional dose of injection hyperbaric ropivacaine (0.75%) in subarachnoid block for patients undergoing Gynaecological surgery.
Not Applicable
- Conditions
- Health Condition 1: - Health Condition 2: O- Medical and SurgicalHealth Condition 3: 8- Other ProceduresHealth Condition 4: N858- Other specified noninflammatory disorders of uterus
- Registration Number
- CTRI/2024/07/071068
- Lead Sponsor
- Kevin Dobariya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with Age group of 18-60 years undergoing elective Gynaecological surgery
Patient with height taller than 140cm and shorter than 180cm.
Patient with BMI more than 18 or less than 25.
Patients with ASA Grade I to III.
Exclusion Criteria
Contraindication of spinal Anaesthesia :local site infection, spine deformities, Coagulopathy, Severely altered mental status, increased ICP.
Allergic to local anaesthetic agent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the hemodynamic changes like Pulse rate(PR), Systolic blood pressure(SBP), Diastolic blood pressure(DBP), Mean arterial pressure(MAP),Blood oxygen saturation (SpO2) in both the groups. <br/ ><br>To compare the duration of analgesia in both the groups. <br/ ><br>Timepoint: 12 months
- Secondary Outcome Measures
Name Time Method To compare the onset, peak and total duration of sensory block. <br/ ><br>To compare the onset, peak and total duration of motor block. <br/ ><br>To compare side effects and complications if any. <br/ ><br>Timepoint: 12 months